Cargando...
Targeting the programmed cell death-1 pathway in rheumatoid arthritis
Since the introduction of TNF-α inhibitors and other biologic agents, the clinical outcome for many treated rheumatoid arthritis patients has significantly improved. However, there are still a substantial proportion of patients that are intolerant, or have inadequate responses, with current agents t...
Gardado en:
| Publicado en: | Autoimmun Rev |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
2017
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5596871/ https://ncbi.nlm.nih.gov/pubmed/28572054 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.autrev.2017.05.025 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|